3C-DFE
| |
| Names | |
|---|---|
| Preferred IUPAC name
1-[4-(2,2-Difluoroethoxy)-3,5-dimethoxyphenyl]propan-2-amine | |
| Other names
3C-DFE
| |
| Identifiers | |
3D model (
JSmol ) |
|
| ChemSpider | |
PubChem CID
|
|
| |
| |
| Properties | |
| C13H19FNO3 | |
| Molar mass | 275.292 g/mol |
| Melting point | 171–172 °C (340–342 °F; 444–445 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
3C-DFE is a lesser-known
psychedelic drug, which is a fluorinated derivative of 3C-E. It was first synthesised by Daniel Trachsel in 2002,[1][2] and has been reported as showing similar psychedelic activity to related compounds, with a dose range of around 20–40 mg and a duration of approximately 10 hours.[3]: 736 Despite its reported psychedelic activity, binding studies in vitro showed 3C-DFE to have a surprisingly weak binding affinity of 2695 nM at 5-HT2A with negligible affinity at 5-HT2C,[3]: 737 making it only slightly higher affinity than mescaline
, despite its higher potency in vivo.
See also
References
- .
- PMID 22374819.
- ^ ISBN 978-3-03788-700-4.
 | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |